Good Life Advisors’s CME Group CME Stock Holding History

Good Life Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,128	Closed	-$469K	–	508
2024 Q3	$469K	Buy	+2,128	New	+$440K	0.03%	359

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Good Life Advisors's CME Position: Q4 2024 in Review

Good Life Advisors sold out of CME Group (CME) in Q4 2024, closing a stake of 2,128 shares — an estimated $469K sold.

Good Life Advisors first reported a position in CME in Q3 2024 and held it in 1 quarter. The position peaked at $469K in Q3 2024. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

Good Life Advisors reported no remaining CME Group position as of Q4 2024 after selling out during the quarter.
Good Life Advisors sold 2,128 CME Group shares in Q4 2024, an estimated $469K.
Good Life Advisors first reported a position in CME Group in Q3 2024 and held it in 1 quarter.
Good Life Advisors's CME Group position peaked at $469K in Q3 2024.
1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on Good Life Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.